PubRank

D W Barry

Author PubWeight™ 58.56‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro. Proc Natl Acad Sci U S A 1985 10.71
2 Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex. Lancet 1986 5.05
3 Isolation and characterisation of resistant Herpes simplex virus after acyclovir therapy. Lancet 1982 2.28
4 Measles infection of human mononuclear cells. I. Acute infection of peripheral blood lymphocytes and monocytes. J Exp Med 1975 1.86
5 Influenza virus infection in nude mice. J Infect Dis 1976 1.85
6 Cytochemistry of tubuloreticular structures in lymphocytes from patients with systemic lupus erythematosus and in cultured human lymphoid cells: comparison to a paramyxovirus. Lab Invest 1973 1.60
7 Pathogenicity of acyclovir-resistant herpes simplex virus type 1 from an immunodeficient child. J Infect Dis 1982 1.56
8 Survival experience among patients with AIDS receiving zidovudine. Follow-up of patients in a compassionate plea program. JAMA 1988 1.51
9 Inhibition of lymphocyte stimulation by measles virus. J Immunol 1975 1.47
10 Clinical isolate of herpes simplex virus type 2 that induces a thymidine kinase with altered substrate specificity. Antimicrob Agents Chemother 1987 1.24
11 Plaque autoradiography assay for the detection and quantitation of thymidine kinase-deficient and thymidine kinase-altered mutants of herpes simplex virus in clinical isolates. Antimicrob Agents Chemother 1985 1.17
12 Virus resistance in clinical practice. J Antimicrob Chemother 1983 1.13
13 In vitro sensitivity to acyclovir in genital herpes simplex viruses from acyclovir-treated patients. J Infect Dis 1983 1.12
14 Comparative trial of influenza vaccines. II. Adverse reactions in children and adults. Am J Epidemiol 1976 1.11
15 Inactivated influenza vaccine efficacy: diminished antigenicity of split-product vaccines in mice. Infect Immun 1974 1.10
16 Recurrent genital herpes and suppressive oral acyclovir therapy. Relation between clinical outcome and in-vitro drug sensitivity. Ann Intern Med 1986 1.09
17 Resistance to arbovirus challenge in mice immediately after vaccination. Appl Microbiol 1973 1.01
18 Comparative trial of influenza vaccines. I. Immunogenicity of whole virus and split product vaccines in man. Am J Epidemiol 1976 0.99
19 Induction of tubular structures in the endoplasmic reticulum of human lymphoid cells by treatment with 5-bromo-2'-deoxyuridine. J Natl Cancer Inst 1973 0.98
20 Colorado tick fever pericarditis. JAMA 1971 0.97
21 Correlation of laboratory studies with clinical responses to A/New Jersey influenza vaccines. J Infect Dis 1977 0.93
22 Oral acyclovir therapy of genital herpes simplex virus type 2 infections in guinea pigs. Antimicrob Agents Chemother 1985 0.92
23 Determination of the viral particle content of influenza vaccines by electron microxcopy. J Biol Stand 1975 0.91
24 Host defence mechanisms against influenza infection. II. Protection of mice with vaccines against A/Port Chalmers/1/73 and B/Hong Kong/5/72. Postgrad Med J 1976 0.91
25 Viral resistance, clinical experience. Scand J Infect Dis Suppl 1985 0.91
26 Spectrum of antiviral activity and mechanism of action of zidovudine. An overview. Am J Med 1988 0.91
27 Antibody production and protection against influenza virus in immunodeficient mice. Infect Immun 1978 0.91
28 HIV-1 inhibition by azidothymidine in a concurrently randomized placebo-controlled trail. J Acquir Immune Defic Syndr 1988 0.87
29 Isolation of foamy virus from rhesus, African green and cynomolgus monkey Leukocytes. J Med Primatol 1975 0.86
30 Orofacial infection of athymic mice with defined mixtures of acyclovir-susceptible and acyclovir-resistant herpes simplex virus type 1. Antimicrob Agents Chemother 1989 0.86
31 Spectrum of sensitivity of acyclovir of herpes simplex virus clinical isolates. Am J Med 1982 0.85
32 Extended acyclovir therapy for herpes genitalis: changes in virus sensitivity and strain variation. J Antimicrob Chemother 1986 0.85
33 Acute and chronic infection of human lymphoblastoid cell lines with measles virus. J Immunol 1976 0.84
34 Induction of acyclovir-resistant mutants of herpes simplex virus type I in athymic nude mice. J Antimicrob Chemother 1986 0.83
35 Disease and latency characteristics of clinical herpes virus isolated after acyclovir therapy. Am J Med 1982 0.81
36 Influenza immunization in chronic bronchitis: local and systemic immune response. Am Rev Respir Dis 1976 0.81
37 Rapid screening of antiretroviral combinations. J Acquir Immune Defic Syndr Hum Retrovirol 1995 0.80
38 Quantitation of influenza vaccine hemagglutinin by immunoelectrophoresis. Dev Biol Stand 1978 0.79
39 Safety assessment, in vitro and in vivo, and pharmacokinetics of emivirine, a potent and selective nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1. Antimicrob Agents Chemother 2000 0.78
40 Evaluation and control of vaccines for the National Influenza Immunization Program. J Infect Dis 1977 0.78
41 Malaria in an infant transmitted by transfusion. JAMA 1968 0.77
42 Clinical and laboratory experience with acyclovir-resistant herpes viruses. J Antimicrob Chemother 1986 0.77
43 Gastrointestinal tuberculosis mimicking cancer--a reminder. Am J Gastroenterol 1978 0.75
44 Poor rectal absorption of trimethoprim/sulphamethoxazole in treating Pneumocystis carinii pneumonia. Postgrad Med J 1981 0.75
45 Inter-Company Collaboration Combination Trials. Clinical Trial Subcommittee of the Inter-Company Collaboration for AIDS Drug Development. J Acquir Immune Defic Syndr Hum Retrovirol 1995 0.75
46 In vitro comparison of selected triple-drug combinations for suppression of HIV-1 replication: the Inter-Company Collaboration Protocol. J Acquir Immune Defic Syndr Hum Retrovirol 1995 0.75
47 Induction of tubuloreticular inclusions in human lymphoma cells (Raji line) related to S-phase treatment with halogenated pyrimidines. Cancer Res 1977 0.75
48 Morphologic, biologic, and cytochemical analysis of intracytoplasmic particles found in cultured fibroblasts from patients with systemic lupus erythematosus. J Invest Dermatol 1974 0.75
49 Prophylactically administered Retrovir in health care workers potentially exposed to the human immunodeficiency virus. J Infect Dis 1988 0.75
50 New initiatives in combination antiretroviral chemotherapy. Adv Exp Med Biol 1996 0.75
51 Endotoxin content and clinical reactivity to influenza vaccines. J Biol Stand 1977 0.75